Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases P Elliott, B Andersson, E Arbustini, Z Bilinska, F Cecchi, P Charron, ... European heart journal 29 (2), 270-276, 2008 | 3800 | 2008 |
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on … ALP Caforio, S Pankuweit, E Arbustini, C Basso, J Gimeno-Blanes, ... European heart journal 34 (33), 2636-2648, 2013 | 3181 | 2013 |
2015 ESC Guidelines for the diagnosis and management of pericardial diseases Y Adler, P Charron, M Imazio, L Badano, G Barón-Esquivias, J Bogaert, ... Polish Heart Journal (Kardiologia Polska) 73 (11), 1028-1091, 2015 | 2446 | 2015 |
The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial P Lechat, KW Brunhuber, R Hofmann, P Kuhn, HJ Nesser, J Slany, ... Lancet 353 (9146), 9-13, 1999 | 2430 | 1999 |
Guidelines on the diagnosis and management of pericardial diseases executive summary: the Task Force on the Diagnosis and Management of Pericardial Diseases of the European … B Maisch, PM Seferović, AD Ristić, R Erbel, R Rienmüller, Y Adler, ... European heart journal 25 (7), 587-610, 2004 | 1424 | 2004 |
Safety of transesophageal echocardiography. A multicenter survey of 10,419 examinations. WG Daniel, R Erbel, W Kasper, CA Visser, R Engberding, GR Sutherland, ... Circulation 83 (3), 817-821, 1991 | 1005 | 1991 |
European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis … AL Caforio, S Pankuweit, E Arbustini, C Basso, J Gimeno-Blanes, SB Felix, ... Eur Heart J 34 (33), 2636-48, 2013 | 630 | 2013 |
Guidelines for the study of familial dilated cardiomyopathies L Mestroni, B Maisch, WJ McKenna, K Schwartz, P Charron, C Rocco, ... European heart journal 20 (2), 93-102, 1999 | 619 | 1999 |
Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study W Grimm, M Christ, J Bach, HH Müller, B Maisch Circulation 108 (23), 2883-2891, 2003 | 467 | 2003 |
Increased osteoprotegerin serum levels in men with coronary artery disease M Schoppet, AM Sattler, JR Schaefer, M Herzum, B Maisch, LC Hofbauer The Journal of Clinical Endocrinology & Metabolism 88 (3), 1024-1028, 2003 | 464 | 2003 |
Task Force on the diagnosis and management of pricardial diseases of the European Society of Cardiology B Maisch Eur Heart J 25, 587-610, 2004 | 452 | 2004 |
International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina E Topol, R Califf, F Van de Werf, R Diaz, E Paolasso, P Aylward, J Simes, ... Circulation 97 (24), 2386-2395, 1998 | 442 | 1998 |
A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy E Villard, C Perret, F Gary, C Proust, G Dilanian, C Hengstenberg, ... European heart journal 32 (9), 1065-1076, 2011 | 370 | 2011 |
The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID) First Epidemiological Results: First Epidemiological Results G Hufnagel, S Pankuweit, A Richter, U Schönian, B Maisch, ... Herz 25, 279-285, 2000 | 361 | 2000 |
Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2 M Spiecker, H Darius, T Hankeln, M Soufi, AM Sattler, JR Schaefer, ... Circulation 110 (15), 2132-2136, 2004 | 313 | 2004 |
Definition of Inflammatory Cardiomyopathy (Myocarditis): On the Way to Consensus A Status Report: A Status Report B Maisch, I Portig, A Ristic, G Hufnagel, S Pankuweit Herz 25, 200-209, 2000 | 306 | 2000 |
A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes GUSTO IIb Investigators N Engl J Med 335, 775-782, 1996 | 302 | 1996 |
Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the … F Schulze, H Lenzen, C Hanefeld, A Bartling, KJ Osterziel, L Goudeva, ... American heart journal 152 (3), 493. e1-493. e8, 2006 | 293 | 2006 |
Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-κB ligand in Monckeberg’s sclerosis and … M Schoppet, N Al-Fakhri, FE Franke, N Katz, PJ Barth, B Maisch, ... The Journal of Clinical Endocrinology & Metabolism 89 (8), 4104-4112, 2004 | 280 | 2004 |
Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS) P Lechat, S Escolano, JL Golmard, H Lardoux, S Witchitz, JA Henneman, ... Circulation 96 (7), 2197-2205, 1997 | 267 | 1997 |